In Media
Menu
  • Irwin Wang – CEO, Reistone Biopharma, China
    Irwin Wang – CEO, Reistone Biopharma, China

    Dr Irwin Wang, CEO of Reistone Biopharma, shares her motivations behind the establishment of the company, their extremely productive collaboration with Jiangsu Hengrui (China's largest pharma company by market capitalization), and their exciting internati

    Learn more
  • Reistone Biopharma: Global Vision from China | Jianghu
    Reistone Biopharma: Global Vision from China | Jianghu

    In October 2018, JAK1 inhibitor SHR0302 of Hengrui Pharmaceutical was approved by FDA to carry out a phase II clinical study for ulcerative colitis; more than one month later, NMPA also approved the clinical trial application

    Learn more